AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ENTACAPONE / LEVODOPA / CARBIDOPA

12 registrations across 1 African market— 12 active

Markets with ENTACAPONE / LEVODOPA / CARBIDOPA

Recent registrations

Brand / ProductMarketHolderStatusExpires
STALEVO 50/12.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 100/25/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 50/12.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 150/37.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 50/12.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 150/37.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 150/37.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 50/12.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 100/25/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 100/25/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 150/37.5/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive
STALEVO 100/25/200 MG
COMPRIME PELLICULE
🇲🇦Moroccoactive

ENTACAPONE / LEVODOPA / CARBIDOPA in Africa — Regulatory Overview

ENTACAPONE / LEVODOPA / CARBIDOPA is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.